Go to the Students section
Go to the Staff section
Go to the Alumni section
Go to the Study here section
Go to the International section
Go to the About section
Go to the Research section
Go to the Business and Employers section
Go to the Support us section
Wed, 27 Feb 2019 15:02:24 GMTThis event offered an excellent opportunity for our hard-working PhD students to showcase their work and receive feedback from a wider audience. In addition to inspiring talks and informative posters, it was also a great chance to talk to trusted suppliers who kindly agreed to sponsor the event.
Tue, 26 Feb 2019 11:14:26 GMTUpdate from WG5 activities at the Prague INDEPTH meeting
Fri, 22 Feb 2019 16:54:33 GMTWith Valentine’s Day still fresh in the memory, why not have a look back at the history of love? Take a trip back to the 18th century, when the art of the love letter reached new heights and matching with a partner was a little more involved than swiping right...
Fri, 22 Feb 2019 15:06:49 GMTPhD, postdoc and bioinformatician positions available in Biology Centre CAS, Ceske Budejovic, CZ.
Thu, 21 Feb 2019 10:59:19 GMTOlder cyclists who use electric bicycles may be getting the same brain benefits as those on standard bikes.
Mon, 18 Feb 2019 11:33:18 GMTThe INDEPTH main meeting in Prague takes places between February 25-27th 2019
Wed, 13 Feb 2019 17:01:38 GMTOxford Brookes University academics from the Faculty of Technology, Design and Environment (TDE) and Faculty of Humanities and Social Sciences (HSS) have combined forces to successfully bid for a research grant to study housing and social care in the UK and Japan.
Mon, 11 Feb 2019 16:37:03 GMTThink opera is highbrow? Think again. Professor Alexandra Wilson’s new book considers the place of opera in the 1920s ‘battle of the brows’.
Wed, 06 Feb 2019 17:05:12 GMTFirst announcement of INDEPTH/SEB Plant Cell Symposium to be held at El Escorial, Madrid in December 2019
Mon, 04 Feb 2019 09:33:32 GMTMore than 4 in 5 men (81%) with prostate cancer struggle with poor sexual function following treatment for the disease, but over half (56%) fail to receive support, according to new research published by the Lancet Oncology.